The DOI matches its Crossref record; 110 of the 110 references it cites were found in a registry or an index.
Eicosanoids
Open accessAbstract
This article describes the pathways of eicosanoid synthesis, eicosanoid receptors, the action of eicosanoids in different physiological systems, the roles of eicosanoids in selected diseases, and the major inhibitors of eicosanoid synthesis and action. Eicosanoids are oxidised derivatives of 20-carbon polyunsaturated fatty acids (PUFAs) formed by the cyclooxygenase (COX), lipoxygenase (LOX) and cytochrome P450 (cytP450) pathways. Arachidonic acid (ARA) is the usual substrate for eicosanoid synthesis. The COX pathways form prostaglandins (PGs) and thromboxanes (TXs), the LOX pathways form leukotrienes (LTs) and lipoxins (LXs), and the cytP450 pathways form various epoxy, hydroxy and dihydroxy derivatives. Eicosanoids are highly bioactive acting on many cell types through cell membrane G-protein coupled receptors, although some eicosanoids are also ligands for nuclear receptors. Because they are rapidly catabolised, eicosanoids mainly act locally to the site of their production. Many eicosanoids have multiple, sometimes pleiotropic, effects on inflammation and immunity. The most widely studied is PGE2. Many eicosanoids have roles in the regulation of the vascular, renal, gastrointestinal and female reproductive systems. Despite their vital role in physiology, eicosanoids are often associated with disease, including inflammatory disease and cancer. Inhibitors have been developed that interfere with the synthesis or action of various eicosanoids and some of these are used in disease treatment, especially for inflammation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kliewer, S. A., Lenhard, J. M., Willson, T. M., Patel, I., Morris, D. C., & Lehmann, J. M. (1995) · Cell · doi:10.1016/0092-8674(95)90194-9 · Cited by 2,028
Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents
Kurumbail, R. G., Stevens, A. M., Gierse, J. K., McDonald, J. J., Stegeman, R. A., Pak, J. Y., Gildehaus, D., iyashiro, J. M., Penning, T. D., Seibert, K., et al. (1996) · Nature · doi:10.1038/384644a0 · Cited by 1,917
Endres, S., Ghorbani, R., Kelley, V. E., Georgilis, K., Lonnemann, G., van der Meer, J. W. M., Cannon, J. G., Rogers, T. S., Klempner, M. S., Weber, P. C., et al. (1989) · New England Journal of Medicine · doi:10.1056/nejm198902023200501 · Cited by 1,910
Wang, D., & DuBois, R. N. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2809 · Cited by 1,793
Marine omega-3 fatty acids and inflammatory processes: effects, mechanisms and clinical relevance
Calder, P. C. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.08.010 · Cited by 1,717
Self-citationRegulation of Immune Responses by Prostaglandin E2
Kalinski, P. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1101029 · Cited by 1,474
Omega-3 fatty acids and inflammatory processes: from molecules to man
Calder, P. C. (2017) · Biochemical Society Transactions · doi:10.1042/bst20160474 · Cited by 1,456
Self-citationLipid mediator class switching during acute inflammation: signals in resolution
Levy, B. D., Clish, C. B., Schmidt, B., Gronert, K., & Serhan, C. N. (2001) · Nature Immunology · doi:10.1038/89759 · Cited by 1,453
Lee, T. H., Hoover, R. L., Williams, J. D., Sperling, R. I., Ravalese, J., Spur, B. W., Robinson, D. R., Corey, E. J., Lewis, R. A., & Austen, K. F. (1985) · New England Journal of Medicine · doi:10.1056/nejm198505093121903 · Cited by 1,333
Anti-inflammatory Properties of Cytochrome P450 Epoxygenase-Derived Eicosanoids
Node, K., Huo, Y., Ruan, X., Yang, B., Spiecker, M., Ley, K., Zeldin, D. C., & Liao, J. K. (1999) · Science · doi:10.1126/science.285.5431.1276 · Cited by 1,215
Dennis, E. A., Cao, J., Hsu, Y.-H., Magrioti, V., & Kokotos, G. (2011) · Chemical Reviews · doi:10.1021/cr200085w · Cited by 1,203
Resolvins and protectins in inflammation resolution
Serhan, C. N., & Petasis, N. A. (2011) · Chemical Reviews · doi:10.1021/cr100396c · Cited by 996
Chinetti, G., Fruchart, J.-C., & Staels, B. (2000) · Inflammation Research · doi:10.1007/s000110050622 · Cited by 954
Lipoxygenase and leukotriene pathways: biochemistry, biology, and roles in disease
Haeggström, J. Z., & Funk, C. D. (2011) · Chemical Reviews · doi:10.1021/cr200246d · Cited by 875
Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis
Nissen, S. E., Yeomans, N. D., Solomon, D. H., Lüscher, T. F., Libby, P., Husni, M. E., Graham, D. Y., Borer, J. S., Wisniewski, L. M., Wolski, K. E., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1611593 · Cited by 856
Enhanced synthesis of leukotriene B4 by colonic mucosa in inflammatory bowel disease
Sharon, P., & Stenson, W. F. (1984) · Gastroenterology · doi:10.1016/s0016-5085(84)80015-3 · Cited by 738
Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes
Tilley, S. L., Coffman, T. M., & Koller, B. H. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200113416 · Cited by 726
Cyclooxygenases: structural and functional insights
Rouzer, C. A., & Marnett, L. J. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800042-jlr200 · Cited by 688
Epoxygenase Pathways of Arachidonic Acid Metabolism
Zeldin, D. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.r100030200 · Cited by 654
von Schacky, C., Fischer, S., & Weber, P. C. (1985) · Journal of Clinical Investigation · doi:10.1172/jci112147 · Cited by 612
Why there are two cyclooxygenase isozymes
Smith, W. L., & Langenbach, R. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13271 · Cited by 611
The resolution code of acute inflammation: Novel pro-resolving lipid mediators in resolution
Serhan, C. N., Chiang, N., & Dalli, J. (2015) · Seminars in Immunology · doi:10.1016/j.smim.2015.03.004 · Cited by 583
Impact of Soluble Epoxide Hydrolase and Epoxyeicosanoids on Human Health
Morisseau, C., & Hammock, B. D. (2013) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011112-140244 · Cited by 537
Enzymes of the Cyclooxygenase Pathways of Prostanoid Biosynthesis
Smith, W. L., Urade, Y., & Jakobsson, P.-J. (2011) · Chemical Reviews · doi:10.1021/cr2002992 · Cited by 503
5-Lipoxygenase, a key enzyme for leukotriene biosynthesis in health and disease
Rådmark, O., Werz, O., Steinhilber, D., & Samuelsson, B. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.08.012 · Cited by 502
Prostaglandin I3 is formed in vivo in man after dietary eicosapentaenoic acid
Fischer, S., & Weber, P. C. (1984) · Nature · doi:10.1038/307165a0 · Cited by 471
The Lipoxin Receptor ALX: Potent Ligand-Specific and Stereoselective Actions in Vivo
Chiang, N., Serhan, C. N., Dahlén, S.-E., Drazen, J. M., Hay, D. W. P., Rovati, G. E., Shimizu, T., Yokomizo, T., & Brink, C. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.4 · Cited by 464
Specialized pro-resolving mediator network: an update on production and actions
Chiang, N., & Serhan, C. N. (2020) · Essays in Biochemistry · doi:10.1042/ebc20200018 · Cited by 438
Knapp, H. R., Reilly, I. A. G., Alessandrini, P., & FitzGerald, G. A. (1986) · New England Journal of Medicine · doi:10.1056/nejm198604103141501 · Cited by 415
Cytosolic phospholipase A2: physiological function and role in disease
Leslie, C. C. (2015) · Journal of Lipid Research · doi:10.1194/jlr.r057588 · Cited by 413
Goodnight, S. J., Harris, W., & Connor, W. (1981) · Blood · doi:10.1182/blood.v58.5.880.880 · Cited by 405
Rees, D., Miles, E. A., Banerjee, T., Wells, S. J., Roynette, C. E., Wahle, K. W., & Calder, P. C. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.2.331 · Cited by 401
Self-citationWada, M., DeLong, C. J., Hong, Y. H., Rieke, C. J., Song, I., Sidhu, R. S., Yuan, C., Warnock, M., Schmaier, A. H., Yokoyama, C., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703169200 · Cited by 400
Marine Omega-3 (N-3) Fatty Acids for Cardiovascular Health: An Update for 2020
Innes, J. K., & Calder, P. C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041362 · Cited by 365
Self-citationSperling, R. I., Benincaso, A. I., Knoell, C. T., Larkin, J. K., Austen, K. F., & Robinson, D. R. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116245 · Cited by 349
Sano, H., Hla, T., Maier, J. A., Crofford, L. J., Case, J. P., Maciag, T., & Wilder, R. L. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115591 · Cited by 345
Resolution phase lipid mediators of inflammation: agonists of resolution
Serhan, C. N., & Chiang, N. (2013) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2013.05.012 · Cited by 331
Yaqoob, Pala, Cortina‐Borja, Newsholme, & Calder (2000) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2000.00623.x · Cited by 308
Lee, T. H., Menica-Huerta, J. M., Shih, C., Corey, E. J., Lewis, R. A., & Austen, K. F. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)43363-1 · Cited by 304
Fatty Acid Substrate Specificities of Human Prostaglandin-endoperoxide H Synthase-1 and −2
Laneuville, O., Breuer, D. K., Xu, N., Huang, Z. H., Gage, D. A., Watson, J. T., Lagarde, M., DeWitt, D. L., & Smith, W. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.33.19330 · Cited by 301
Liu, Y., Zhang, Y., Schmelzer, K., Lee, T.-S., Fang, X., Zhu, Y., Spector, A. A., Gill, S., Morisseau, C., Hammock, B. D., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508081102 · Cited by 300
Goldman, D. W., Pickett, W. C., & Goetzl, E. J. (1983) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(83)91572-3 · Cited by 294
Molecular Mechanism of Thromboxane A2-induced Platelet Aggregation
Paul, B. Z. S., Jin, J., & Kunapuli, S. P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.41.29108 · Cited by 276
Wagner, K. M., McReynolds, C. B., Schmidt, W. K., & Hammock, B. D. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.06.006 · Cited by 270
Lipoxin A4: A New Class of Ligand for the Ah Receptor
Schaldach, C. M., Riby, J., & Bjeldanes, L. F. (1999) · Biochemistry · doi:10.1021/bi982861e · Cited by 264
Molecular mechanisms underlying prostaglandin E2-exacerbated inflammation and immune diseases
Tsuge, K., Inazumi, T., Shimamoto, A., & Sugimoto, Y. (2019) · International Immunology · doi:10.1093/intimm/dxz021 · Cited by 263
Serhan, C. N. (2017) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2017.03.001 · Cited by 257
Cyclooxygenase inhibitors: From pharmacology to clinical read-outs
Patrignani, P., & Patrono, C. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.09.016 · Cited by 239
Cytochrome P450 epoxygenase pathway of polyunsaturated fatty acid metabolism
Spector, A. A., & Kim, H.-Y. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.07.020 · Cited by 237
Molecular basis of cyclooxygenase enzymes (COXs) selective inhibition
Limongelli, V., Bonomi, M., Marinelli, L., Gervasio, F. L., Cavalli, A., Novellino, E., & Parrinello, M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0913377107 · Cited by 226
Oxidation of polyunsaturated fatty acids to produce lipid mediators
Christie, W. W., & Harwood, J. L. (2020) · Essays in Biochemistry · doi:10.1042/ebc20190082 · Cited by 216
Prostaglandin D2 pathway upregulation: Relation to asthma severity, control, and TH2 inflammation
Fajt, M. L., Gelhaus, S. L., Freeman, B., Uvalle, C. E., Trudeau, J. B., Holguin, F., & Wenzel, S. E. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.01.035 · Cited by 211
Cytochrome P450-derived eicosanoids: the neglected pathway in cancer
Panigrahy, D., Kaipainen, A., Greene, E. R., & Huang, S. (2010) · Cancer and Metastasis Reviews · doi:10.1007/s10555-010-9264-x · Cited by 199
Muthalif, M. M., Benter, I. F., Karzoun, N., Fatima, S., Harper, J., Uddin, M. R., & Malik, K. U. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.21.12701 · Cited by 197
The role of prostaglandins in human parturition
Gibb, W. (1998) · Annals of Medicine · doi:10.3109/07853899809005850 · Cited by 189
n -3 PUFA and inflammation: from membrane to nucleus and from bench to bedside
Calder, P. C. (2020) · Proceedings of The Nutrition Society · doi:10.1017/s0029665120007077 · Cited by 186
Self-citationLipoxins and aspirin-triggered lipoxins in resolution of inflammation
Romano, M., Cianci, E., Simiele, F., & Recchiuti, A. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.03.083 · Cited by 183
Feltenmark, S., Gautam, N., Brunnström, Å., Griffiths, W., Backman, L., Edenius, C., Lindbom, L., Björkholm, M., & Claesson, H.-E. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710127105 · Cited by 183
Park, G. Y., & Christman, J. W. (2006) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00513.2005 · Cited by 182
Cytochrome P450–dependent metabolism of ω-6 and ω-3 long-chain polyunsaturated fatty acids
Arnold, C., Konkel, A., Fischer, R., & Schunck, W.-H. (2010) · Pharmacological Reports · doi:10.1016/s1734-1140(10)70311-x · Cited by 174
Physiologic and pathophysiologic roles of lipid mediators in the kidney
Hao, C.-M., & Breyer, M. D. (2007) · Kidney International · doi:10.1038/sj.ki.5002192 · Cited by 166
Leukotriene biosynthetic enzymes as therapeutic targets
Haeggström, J. Z. (2018) · Journal of Clinical Investigation · doi:10.1172/jci97945 · Cited by 166
Niringiyumukiza, J. D., Cai, H., & Xiang, W. (2018) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-018-0359-5 · Cited by 163
Bachschmid, M. M., Schildknecht, S., Matsui, R., Zee, R. S., Haeussler, D. J., Cohen, R. A., Pimental, D. R., & van der Loo, B. (2012) · Annals of Medicine · doi:10.3109/07853890.2011.645498 · Cited by 159
Rosolowsky, M., & Campbell, W. B. (1996) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(95)00216-2 · Cited by 158
The Role of Leukotrienes as Potential Therapeutic Targets in Allergic Disorders
Jo‐Watanabe, A., Okuno, T., & Yokomizo, T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20143580 · Cited by 158
Prostacyclin: An Inflammatory Paradox
Stitham, J., Midgett, C. R., Martin, K. A., & Hwa, J. (2011) · Frontiers in Pharmacology · doi:10.3389/fphar.2011.00024 · Cited by 154
Glucocorticosteroid action on the immune system: molecular and cellular aspects.
Dt, B., Paliogianni, F., Ed, A., et al. (1991) · PubMed · Cited by 153
Hirata, T., & Narumiya, S. (2011) · Chemical Reviews · doi:10.1021/cr200010h · Cited by 148
Molecular mechanisms involved in the regulation of prostaglandin biosynthesis by glucocorticoids
Goppelt‐Struebe, M. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00018-x · Cited by 142
Thromboxane and the thromboxane receptor in cardiovascular disease
Smyth, E. M. (2010) · Clinical Lipidology · doi:10.2217/clp.10.11 · Cited by 141
Cytochrome P450 ω-Hydroxylases in Inflammation and Cancer
Johnson, A. L., Edson, K. Z., Totah, R. A., & Rettie, A. E. (2015) · Advances in pharmacology · doi:10.1016/bs.apha.2015.05.002 · Cited by 131
Needleman, P., Whitaker, M. O., Wyche, A. A., Watters, K., Sprecher, H. W., & Raz, A. (1980) · Prostaglandins · doi:10.1016/0090-6980(80)90163-x · Cited by 130
Prostacyclin in Vascular Diseases - Recent Insights and Future Perspectives -
Kawabe, J.-I., Ushikubi, F., & Hasebe, N. (2010) · Circulation Journal · doi:10.1253/circj.cj-10-0195 · Cited by 119
Ekambaram, P., Lambiv, W. L., Cazzolli, R., Ashton, A. W., & Honn, K. V. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9297-9 · Cited by 118
Prostaglandin synthases: Molecular characterization and involvement in prostaglandin biosynthesis
Seo, M., & Oh, D. (2017) · Progress in Lipid Research · doi:10.1016/j.plipres.2017.04.003 · Cited by 115
PGD Synthase and PGD 2 in Immune Resposne
Joo, M., & Sadikot, R. T. (2012) · Mediators of Inflammation · doi:10.1155/2012/503128 · Cited by 112
Cysteinyl leukotriene receptors, old and new; implications for asthma
Laidlaw, T. M., & Boyce, J. A. (2012) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2012.03982.x · Cited by 108
Barnig, C., Bezema, T., Calder, P. C., Charloux, A., Frossard, N., Garssen, J., Haworth, O., Dilevskaya, K., Levi‐Schaffer, F., Lonsdorfer‐Wolf, E., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01699 · Cited by 106
Self-citationEndogenous Anti-inflammatory Mediators from Arachidonate in Human Neutrophils
Vachier, I., Chanez, P., Bonnans, C., Godard, P., Bousquet, J., & Chavis, C. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.6155 · Cited by 100
Evolutionary aspects of lipoxygenases and genetic diversity of human leukotriene signaling
Horn, T. L., Adel, S., Schumann, R. R., Sur, S., Kakularam, K. R., Aparoy, P., Reddanna, P., Kühn, H., & Heydeck, D. (2014) · Progress in Lipid Research · doi:10.1016/j.plipres.2014.11.001 · Cited by 100
Transcellular biosynthesis of eicosanoid lipid mediators
Capra, V., Rovati, G. E., Mangano, P., Buccellati, C., Murphy, R. C., & Sala, A. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.09.002 · Cited by 98
The prostaglandin D2 receptor 2 pathway in asthma: a key player in airway inflammation
Domingo, C., Palomares, Ó., Sandham, D. A., Erpenbeck, V. J., & Altman, P. (2018) · Respiratory Research · doi:10.1186/s12931-018-0893-x · Cited by 94
Cyclooxygenase-3: axiom, dogma, anomaly, enigma or splice error?--Not as easy as 1, 2, 3.
Davies, N. M., Good, R. L., Roupe, K., & Yáñez, J. A. (2004) · PubMed · Cited by 93
Prospective for cytochrome P450 epoxygenase cardiovascular and renal therapeutics
Imig, J. D. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.06.015 · Cited by 91
Prostacyclin signaling in the kidney: implications for health and disease
Nasrallah, R., & Hébert, R. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00454.2004 · Cited by 88
Vascular Pharmacology of Epoxyeicosatrienoic Acids
Pfister, S. L., Gauthier, K. M., & Campbell, W. B. (2010) · Advances in pharmacology · doi:10.1016/b978-0-12-385061-4.00002-7 · Cited by 85
Masoodi, M., Pearl, D. S., Eiden, M. J., Shute, J. K., Brown, J. F., Calder, P. C., & Trebble, T. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076532 · Cited by 84
Self-citationBiosynthesis of leukotriene B4
Wan, M., Tang, X. Y., Stsiapanava, A., & Haeggström, J. Z. (2017) · Seminars in Immunology · doi:10.1016/j.smim.2017.07.012 · Cited by 82
Miles, E. A., Allen, E., & Calder, P. C. (2002) · Cytokine · doi:10.1006/cyto.2002.2007 · Cited by 80
Self-citationCrescente, M., Menke, L., Chan, M. V., Armstrong, P. C. J., & Warner, T. D. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14196 · Cited by 78
Brudvik, K. W., & Taskén, K. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01800.x · Cited by 76
Prostaglandins and the Regulation of Tumor Growth
Bishop‐Bailey, D., Calatayud, S., Warner, T. D., et al. (2002) · Journal of Environmental Pathology Toxicology and Oncology · doi:10.1615/jenvironpatholtoxicoloncol.v21.i2.20 · Cited by 76
Medhora, M. M., Chen, Y., Gruenloh, S. K., Harland, D. R., Bodiga, S., Zielonka, J., Gebremedhin, D., Gao, Y., Falck, J. R., Anjaiah, S., et al. (2008) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00278.2007 · Cited by 76
Expression, localization and function of prostaglandin receptors in myometrium
Myatt, L., & Lye, S. J. (2003) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2003.04.004 · Cited by 73
Importance of the leukotriene B4-BLT1 and LTB4-BLT2 pathways in asthma
Gelfand, E. W. (2017) · Seminars in Immunology · doi:10.1016/j.smim.2017.08.005 · Cited by 73
Targeting the Prostacyclin Pathway: Beyond Pulmonary Arterial Hypertension
Pluchart, H., Khouri, C., Blaise, S., Roustit, M., & Cracowski, J. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.03.003 · Cited by 66
Role of Cytochrome P450s in Inflammation
Christmas, P. (2015) · Advances in pharmacology · doi:10.1016/bs.apha.2015.03.005 · Cited by 63
Role of prostaglandins in tumor microenvironment
Kobayashi, K., Omori, K., & Murata, T. (2018) · Cancer and Metastasis Reviews · doi:10.1007/s10555-018-9740-2 · Cited by 62
Prostanoids and leukotrienes in the pathophysiology of atopic dermatitis and psoriasis
Honda, T., & Kabashima, K. (2019) · International Immunology · doi:10.1093/intimm/dxy087 · Cited by 59
Brandt, S. L., & Serezani, C. H. (2017) · Seminars in Immunology · doi:10.1016/j.smim.2017.08.006 · Cited by 58
Innate immunity is a key factor for the resolution of inflammation in asthma
Barnig, C., & Levy, B. D. (2015) · European Respiratory Review · doi:10.1183/09059180.00012514 · Cited by 56
Pathophysiology of the hepoxilins
Pace-Asciak, C. R. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.09.007 · Cited by 43
Moore, M. L., & Peebles, R. S. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.12.1314 · Cited by 41
Vascular effects of prostacyclin: does activation of PPARδ play a role?
Katušić, Z. S., Santhanam, A. V. R., & He, T. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.05.005 · Cited by 38
Prostanoid Signal Integration and Cross Talk
Wise, H. M., Wong, Y. H., & Jones, R. L. (2002) · Neurosignals · doi:10.1159/000057318 · Cited by 36
Physiological and pathophysiological implications of PGE2 and the PGE2 synthases in the kidney
Wang, J., Liu, M., Zhang, X., Yang, G., & Chen, L. (2017) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2017.10.006 · Cited by 28
New insights into eicosanoid biosynthetic pathways: implications for arthritis
Kojima, F., Kapoor, M., Kawai, S., & Crofford, L. J. (2006) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2.2.277 · Cited by 25
Capdevila, J. H., & Falck, J. R. (2018) · Journal of Lipid Research · doi:10.1194/jlr.r087882 · Cited by 20
Role of prostacyclin synthase in carcinogenesis
Sasaki, Y., Ochiai, T., Takamura, M., Kondo, Y., Yokoyama, C., & Hara, S. (2017) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2017.05.001 · Cited by 18
Cited by
Djuricic, I., & Calder, P. C. (2021) · Nutrients · doi:10.3390/nu13072421 · Cited by 1,015
Self-citationDyall, S. C., Balas, L., Bazan, N. G., Brenna, J. T., Chiang, N., da Costa Souza, F., Dalli, J., Durand, T., Galano, J.-M., Lein, P. J., et al. (2022) · Progress in Lipid Research · doi:10.1016/j.plipres.2022.101165 · Cited by 660
Metadata
- Authors
- Calder, P. C.
- Venue
- Essays in Biochemistry
- Publisher
- Portland Press Ltd.
- Published
- 2020-08-18
- Volume
- 64
- Issue
- 3
- Pages
- 423-441
- ISSN
- 0071-1365 (ISSN-L)
- 1744-1358
- OpenAlex
- W4211237661
- Cited by
- 321
- References
- 110
- FWCI
- 18.02
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.